1: To determine the appropriate label for the task of assessing the risks and benefits of therapies for allergic and immunologic disorders as an Allergist and Immunologist, we need to consider the nature of the task and how it can be supported by the capabilities of the LLM.

- The task involves evaluating the risks and benefits of different therapies, which requires a deep understanding of medical knowledge, research, and patient-specific factors.
- The LLM can provide general information on therapies, potential side effects, and benefits based on existing data and research.
- However, the task also involves interpreting complex medical data, understanding the nuances of individual patient cases, and making informed decisions based on the latest research and guidelines.
- While the LLM can provide some information and insights, it may not have access to the most up-to-date medical research and guidelines unless explicitly provided in the input.
- The task also requires a high level of expertise and experience in the field of allergy and immunology, which the LLM may not fully possess.

Based on these considerations, the task of assessing the risks and benefits of therapies for allergic and immunologic disorders as an Allergist and Immunologist would likely fall under label E2 - Exposure by LLM-powered applications. While the LLM can provide some support in terms of general information and insights, additional software specifically tailored to medical research, guidelines, and patient-specific data would be needed to significantly reduce the time it takes to complete the task.

2: E2

3: Moderate